Angelini Pharma Completes $4.1 Billion Acquisition of Catalyst Pharmaceuticals
ROME & CORAL GABLES, Fla., July 16, 2026 Angelini Pharma has completed its acquisition of Catalyst Pharmaceuticals, marking a...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
ROME & CORAL GABLES, Fla., July 16, 2026 Angelini Pharma has completed its acquisition of Catalyst Pharmaceuticals, marking a...
LONDON, UK, July 6, 2026 Cumulus Neuroscience announced a strategic collaboration with Muse by Interaxon to integrate validated at-home...
INDIANAPOLIS, June 24, 2026 Eli Lilly and Company announced the successful completion of its acquisition of Centessa Pharmaceuticals plc,...
BOSTON, Mass., June 20, 2026 Velico Medical has announced successful results from its Phase 1 first-in-human clinical trial evaluating...
MISSION VIEJO, Calif., June 20, 2026 Kyowa Hakko USA has unveiled promising new research demonstrating the potential acute cognitive...
HOUSTON, Texas, June 16, 2026 Nexalin Technology announced that two clinical abstracts evaluating its proprietary Deep Intracranial Frequency Stimulation...
GOTHENBURG, Sweden, June 13, 2026 MGI Tech Co., Ltd. (MGI) unveiled major initiatives to strengthen the global genomics ecosystem...
VANCOUVER, Wash., June 11, 2026 CytoDyn Inc. announced that the first patient has been dosed in the Phase 2a...
JACKSONVILLE, Fla., June 11, 2026 Johnson & Johnson has announced the expanded U.S. availability of its TECNIS PureSee Intraocular...
BEIJING, China, June 12, 2026 Datasea Intelligent Technology Ltd. (NASDAQ: DTSS) has announced a significant step forward in its...
